Spire Wealth Management’s bluebird bio BLUE Stock Holding History
Bought
Maintained
Sold
Other funds holding BLUE
TCM
BBA
Spire Wealth Management's BLUE Position: Q2 2022 in Review
Spire Wealth Management sold out of bluebird bio (BLUE) in Q2 2022, closing a stake of 16 shares — an estimated $2K sold.
Spire Wealth Management first reported a position in BLUE in Q1 2021 and held it in 5 quarters. The position peaked at $10K in Q2 2021. 151 funds tracked by Wall St. Rank hold BLUE as of Q2 2022.
- Spire Wealth Management reported no remaining bluebird bio position as of Q2 2022 after selling out during the quarter.
- Spire Wealth Management sold 16 bluebird bio shares in Q2 2022, an estimated $2K.
- Spire Wealth Management first reported a position in bluebird bio in Q1 2021 and held it in 5 quarters.
- Spire Wealth Management's bluebird bio position peaked at $10K in Q2 2021.
- 151 funds tracked by Wall St. Rank held bluebird bio as of Q2 2022.
Based on Spire Wealth Management's 13F filing for Q2 2022, filed 22 Jul 2022.